Analysis of EGFR Mutation Status in Algerian Patients with Non-Small Cell Lung Cancer

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) mutation status is used as a predictive biomarker for the tyrosine kinase inhibitors therapy in non-small cell lung cancer (NSCLC). The incidence of EGFR mutations appears to vary according to ethnic and geographical backgrounds. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahmadi, Mohamed, Beddar, Leila, Rouibah, Amira Lyna, Boumegoura, Ali, Boufendi, Houda, Temim, Asma, Nini, Anissa, Sellam, Feriel, Satta, Dalila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325123/
https://www.ncbi.nlm.nih.gov/pubmed/33906297
http://dx.doi.org/10.31557/APJCP.2021.22.4.1063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325123/
https://www.ncbi.nlm.nih.gov/pubmed/33906297
http://dx.doi.org/10.31557/APJCP.2021.22.4.1063

Ejemplares similares